ACTR-38. A SINGLE CENTER STUDY: LONG-TERM OUTCOMES OF COMBINED CHEMORADIATION THERAPY WITH TEMOZOLOMIDE FOR NEWLY DIAGNOSED GLIOBLASTOMA IN KOREAN PATIENT

In newly diagnosed glioblastoma (GBM), Temozolomide (TMZ) during and after radiation therapy has become standard treatment. This study describes the long-term use and follow-up results of this therapy for GBM. From 2004 to 2013 in a single institute, 112 Korean patients with newly diagnosed GBM were...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Neuro Oncol
Hlavní autoři: Go, Kyeong-O, Young Yang, Ha, Hwang, Kihwan, Ho Han, Jung, Soo Choi, Hyoung, Jung Kim, Yu, Woo Wee, Chan, Ah Kim, In, Choe, Gheeyoung, Kim, Chae-Yong
Médium: Artigo
Jazyk:Inglês
Vydáno: Oxford University Press 2019
Témata:
Adult Clinical Trials - Non-Immunologic
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6847143/
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/neuonc/noz175.080
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky